Changes in synovial fluid biomarkers after experimental equine osteoarthritis

1. Alwan W.H., Carter S.D., Bennett D., Edwards G.B.: Glycosaminoglycans in horses with osteoarthritis. Equine Vet J 1991, 23, 44–47.10.1111/j.2042-3306.1991.tb02712.x1901787Search in Google Scholar

2. Bai B., Li Y.: Combined detection of serum CTX-II and COMP concentrations in osteoarthritis model rabbits: an effective technique for early diagnosis and estimation of disease severity. J Orthopaedic Surg Res 2016, 11, 149.10.1186/s13018-016-0483-x512043627876074Search in Google Scholar

3. Barrachina L., Remacha A.R., Soler L., García N., Romero A., Vázquez F.J., Vitoria A., Álava M.Á., Lamprave F., Rodellar C.: Acute phase protein haptoglobin as inflammatory marker in serum and synovial fluid in an equine model of arthritis. Vet Immunol Immunopathol 2016, 182, 74–78.10.1016/j.vetimm.2016.10.00527863554Search in Google Scholar

4. Clegg P.D., Coughlan A.R., Riggs C.M., Carter S.D.: Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine Vet J 1997, 29, 343–348.10.1111/j.2042-3306.1997.tb03137.x9306059Open DOISearch in Google Scholar

5. de Bakker E., Stroobants V., VanDael F., Ryssen B.V., Meyer E.: Canine synovial fluid biomarkers for early detection and monitoring of osteoarthritis. Vet Rec 2017, 180, 328–329.10.1136/vr.10398228364073Search in Google Scholar

6. de Grauw J.C., van de Lest C.H.A., van Weeren P.R.: Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 2009, 11, R35.10.1186/ar2640268818019272138Open DOISearch in Google Scholar

7. Frisbie D.D., Al-Sobayil F., Billinghurst R.C., Kawcak C.E., McIlwraith C.W.: Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 2008, 16, 1196–1204.10.1016/j.joca.2008.03.00818442931Search in Google Scholar

8. Fuller C., Barr A.R., Sharif M., Dieppe P.: Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001, 9, 49–55.10.1053/joca.2000.034911178947Search in Google Scholar

9. Garner B., Stoker A., Kuroki K., Evans R., Cook C.R., Cook J.: Using animal models in osteoarthritis biomarker research. J Knee Surg 2001, 24, 251–264.10.1055/s-0031-129736122303754Open DOISearch in Google Scholar

10. Gaudin P., Razakaboay M., Surla A., Berthier S., Fauconnier J., Morel F., Phelip X.: A study of metalloproteinases in fifty joint fluid specimens. Rev Rhumat 1997, 64, 375–381.Search in Google Scholar

11. Gendron C., Kashiwagi M., Lim N.H., Enghild J.J., Thøgersen I.B., Hughes C., Caterson B., Nagase H.: Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 2007, 282, 18294–18306.10.1074/jbc.M70152320017430884Search in Google Scholar

12. Heinegård D., Saxne T.: The role of the cartilage matrix in osteoarthritis. Nature Rev Rheumatol 2001, 7, 50–56.10.1038/nrrheum.2010.19821119607Search in Google Scholar

13. Iwai K.: Diverse ubiquitin signaling in NF-κB activation. Trends Cell Biol 2012, 22, 355–364.10.1016/j.tcb.2012.04.00122543051Open DOISearch in Google Scholar

14. Jouglin M., Robert C., Valette J.P., Gavard F., Quintin-Colonna F., Denoix J.M.: Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Vet Res 2000, 31, 507–515.10.1051/vetres:2000136Open DOISearch in Google Scholar

15. Kamarainen O.P., Solovieva S., Vehmas T., Luoma K., Riihimaki H., Ala-Kokko L., Mannikko M., Leino-Arjas P.: Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther 2008, 10, R21.10.1186/ar2374237445818257935Search in Google Scholar

16. Kamm J.L., Nixon A.J., Witte T.H.: Cytokine and catabolic enzyme expression in synovium, synovial fluid, and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J 2010, 42, 693–699.10.1111/j.2042-3306.2010.00140.x418375521039798Open DOISearch in Google Scholar

17. Kapoor M., Martelpelletier J., Lajeunesse D., Pelletier J.P., Fahmi H.: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Prog Modern Biomed 2014, 7, 33–42.10.1038/nrrheum.2010.19621119608Search in Google Scholar

18. Kozaci L.D., Buttle D.J., Hollander A.P.: Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheumatol 1997, 40, 164–174.10.1002/art.17804001219008612Search in Google Scholar

19. Maldonado M., Nam J.: The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013, 2013, 284873.10.1155/2013/284873377124624069595Search in Google Scholar

20. Marttinen P.H., Raulo S.M., Suominen M.M., Tulamo R.M.: Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac. J Vet Med 2006, 53, 311–318.10.1111/j.1439-0442.2006.00837.x16901276Search in Google Scholar

21. Mokbel A.N., El Tookhy O.S., Shamaa A.A., Rashed L.A., Sabry D., El Sayed A.M.: Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011, 12, 259.10.1186/1471-2474-12-259323243822085445Search in Google Scholar

22. Sawaji Y., Hynes J., Vincent T., Saklatvala J.: Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008, 58, 3498–3509.10.1002/art.2402518975307Open DOISearch in Google Scholar

23. Skioldebrand E., Ekman S., Mattsson Hulten L., Svala E., Bjorkman K., Lindahl A., Lundqvist A., Onnerfjord P., Sihlbom C., Ruetschi U.: Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis. Equine Vet J 2017, 49, 662–667.10.1111/evj.12666557394628097685Search in Google Scholar

24. Skioldebrand E., Heinegard D., Eloranta M.L., Nilsson G., Dudhia J., Sandgren B., Ekman S.: Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds. J Orthop Res 2005, 23, 156–163.10.1016/j.orthres.2004.05.01315607888Open DOISearch in Google Scholar

25. Trumble T.N., Trotter G.W., Oxford J.R., McIlwraith C.W., Cammarata S., Goodnight J.L., Billinghurst R.C., Frisbie D.D.: Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 2001, 62, 1467–1477.10.2460/ajvr.2001.62.146711560279Open DOISearch in Google Scholar

26. Boom R., Brama P.A., Geesje H., Kiers G.H., Groot K.J., Weeren P.R.: Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses. Am J Vet Res 2004, 65, 296–302.10.2460/ajvr.2004.65.29615027675Open DOISearch in Google Scholar

27. Verma P., Dalal K.: ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011, 112, 3507–3514.10.1002/jcb.2329821815191Search in Google Scholar

28. Wang G., Li X., Jiang R., Li Y., Fan X., Zheng Y., Gao L.: Changes in synovial fluid inflammatory mediators and cartilage biomarkers after experimental acute equine synovitis. Bull Vet Inst Pulawy 2015, 59, 129–131.10.1515/bvip-2015-0019Search in Google Scholar

29. Zheng W., Zhang H., Jin Y., Wang Q., Chen L., Feng Z., Chen H., Wu Y.: Butein inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes and slows the progression of osteoarthritis in mice. Int Immunopharmacol 2017, 42, 1–10.10.1016/j.intimp.2016.11.00927863298Search in Google Scholar